Cargando…
The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation
In cases of accidental high-dose total-body irradiation (TBI), acute radiation syndrome (ARS) can cause death. We reported that the thrombopoietin receptor agonist romiplostim (RP) has the potential to completely rescue mice exposed to lethal TBI. Extracellular vesicles (EVs) are involved in cell-to...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216450/ https://www.ncbi.nlm.nih.gov/pubmed/37238707 http://dx.doi.org/10.3390/biom13050837 |
_version_ | 1785048301159055360 |
---|---|
author | Yamaguchi, Masaru Kashiwakura, Ikuo |
author_facet | Yamaguchi, Masaru Kashiwakura, Ikuo |
author_sort | Yamaguchi, Masaru |
collection | PubMed |
description | In cases of accidental high-dose total-body irradiation (TBI), acute radiation syndrome (ARS) can cause death. We reported that the thrombopoietin receptor agonist romiplostim (RP) has the potential to completely rescue mice exposed to lethal TBI. Extracellular vesicles (EVs) are involved in cell-to-cell communication, and the mechanism of RP action may be related to EVs that reflect the radio-mitigative information. We investigated the radio-mitigative effects of EVs on mice with severe ARS. C57BL/6 mice exposed to lethal TBI were treated with RP, and the EVs were isolated from the serum and intraperitoneally injected into other mice with severe ARS. The 30-day survival rate of lethal TBI mice drastically improved by 50–100% with the administration of EVs in the sera collected weekly from the mice in which radiation damage was alleviated and mortality was avoided by the administration of RP. Four responsive miRNAs, namely, miR-144-5p, miR-3620-5p, miR-6354, and miR-7686-5p showed significant expression changes in an array analysis. In particular, miR-144-5p was expressed only in the EVs of RP-treated TBI mice. Specific EVs may exist in the circulating blood of mice that escaped mortality with an ARS mitigator, and their membrane surface and endogenous molecules may be the key to the survival of mice with severe ARS. |
format | Online Article Text |
id | pubmed-10216450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102164502023-05-27 The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation Yamaguchi, Masaru Kashiwakura, Ikuo Biomolecules Article In cases of accidental high-dose total-body irradiation (TBI), acute radiation syndrome (ARS) can cause death. We reported that the thrombopoietin receptor agonist romiplostim (RP) has the potential to completely rescue mice exposed to lethal TBI. Extracellular vesicles (EVs) are involved in cell-to-cell communication, and the mechanism of RP action may be related to EVs that reflect the radio-mitigative information. We investigated the radio-mitigative effects of EVs on mice with severe ARS. C57BL/6 mice exposed to lethal TBI were treated with RP, and the EVs were isolated from the serum and intraperitoneally injected into other mice with severe ARS. The 30-day survival rate of lethal TBI mice drastically improved by 50–100% with the administration of EVs in the sera collected weekly from the mice in which radiation damage was alleviated and mortality was avoided by the administration of RP. Four responsive miRNAs, namely, miR-144-5p, miR-3620-5p, miR-6354, and miR-7686-5p showed significant expression changes in an array analysis. In particular, miR-144-5p was expressed only in the EVs of RP-treated TBI mice. Specific EVs may exist in the circulating blood of mice that escaped mortality with an ARS mitigator, and their membrane surface and endogenous molecules may be the key to the survival of mice with severe ARS. MDPI 2023-05-15 /pmc/articles/PMC10216450/ /pubmed/37238707 http://dx.doi.org/10.3390/biom13050837 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yamaguchi, Masaru Kashiwakura, Ikuo The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation |
title | The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation |
title_full | The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation |
title_fullStr | The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation |
title_full_unstemmed | The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation |
title_short | The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation |
title_sort | acute radiation syndrome-mitigator romiplostim and secreted extracellular vesicles improved survival in mice acutely exposed to myelosuppressive doses of ionizing radiation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216450/ https://www.ncbi.nlm.nih.gov/pubmed/37238707 http://dx.doi.org/10.3390/biom13050837 |
work_keys_str_mv | AT yamaguchimasaru theacuteradiationsyndromemitigatorromiplostimandsecretedextracellularvesiclesimprovedsurvivalinmiceacutelyexposedtomyelosuppressivedosesofionizingradiation AT kashiwakuraikuo theacuteradiationsyndromemitigatorromiplostimandsecretedextracellularvesiclesimprovedsurvivalinmiceacutelyexposedtomyelosuppressivedosesofionizingradiation AT yamaguchimasaru acuteradiationsyndromemitigatorromiplostimandsecretedextracellularvesiclesimprovedsurvivalinmiceacutelyexposedtomyelosuppressivedosesofionizingradiation AT kashiwakuraikuo acuteradiationsyndromemitigatorromiplostimandsecretedextracellularvesiclesimprovedsurvivalinmiceacutelyexposedtomyelosuppressivedosesofionizingradiation |